Adjuvant application of interferons

Semin Oncol. 1996 Dec;23(6):737-43.
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Cancer Vaccines / therapeutic use
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Dose-Response Relationship, Immunologic
  • Drug Combinations
  • Female
  • G(M2) Ganglioside / therapeutic use
  • Humans
  • Interferon Type I / administration & dosage
  • Interferon Type I / therapeutic use*
  • Interferon-gamma / administration & dosage
  • Interferon-gamma / therapeutic use
  • Interleukin-2 / administration & dosage
  • Male
  • Melanoma / pathology
  • Melanoma / surgery
  • Melanoma / therapy*
  • Multicenter Studies as Topic
  • Neoplasm Staging
  • Recombinant Proteins
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Skin Neoplasms / therapy*
  • Vaccines, Conjugate / therapeutic use

Substances

  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Cancer Vaccines
  • Drug Combinations
  • Interferon Type I
  • Interleukin-2
  • Recombinant Proteins
  • Vaccines, Conjugate
  • G(M2) Ganglioside
  • Interferon-gamma